MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

Search

Maravai LifeSciences Holdings Inc (Class A)

Закрыт

3.32 0.61

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

3.25

Макс.

3.39

Ключевые показатели

By Trading Economics

Доход

-17M

-70M

Продажи

547K

47M

Рентабельность продаж

-147.345

Сотрудники

560

EBITDA

-17M

-66M

Рекомендации

By TipRanks

Рекомендации

Покупка

Прогноз на 12 месяцев

+49.68% upside

Дивиденды

By Dow Jones

Следующий отчет о доходах

6 нояб. 2025 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

389M

1.1B

Предыдущая цена открытия

2.71

Предыдущая цена закрытия

3.32

Техническая оценка

By Trading Central

Уверенность

Bullish Evidence

Maravai LifeSciences Holdings Inc (Class A) График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

7 окт. 2025 г., 16:58 UTC

Отчет

BMW Trims 2025 View, Citing Weaker Performance in China

7 окт. 2025 г., 23:43 UTC

Обсуждения рынка

Nikkei May Trade Rangebound; Takaichi's Policy Steps in Focus -- Market Talk

7 окт. 2025 г., 23:36 UTC

Обсуждения рынка

Gold Edges Higher, Supported by Possible Hedging Demand -- Market Talk

7 окт. 2025 г., 23:19 UTC

Обсуждения рынка

Veem Can Secure More Defense Deals Following Northrop Grumman Win -- Market Talk

7 окт. 2025 г., 22:50 UTC

Обсуждения рынка

Global Forex and Fixed Income Roundup: Market Talk

7 окт. 2025 г., 22:50 UTC

Обсуждения рынка

RBNZ Should Take the Option of a Bigger Cut -- Market Talk

7 окт. 2025 г., 22:40 UTC

Обсуждения рынка

South32's Alaskan Project Seen Starting Sooner, Worth More After U.S. Deal -- Market Talk

7 окт. 2025 г., 21:56 UTC

Обсуждения рынка

Global Equities Roundup: Market Talk

7 окт. 2025 г., 21:56 UTC

Обсуждения рынка

Australia Shares Set to Start Day Roughly Flat -- Market Talk

7 окт. 2025 г., 20:50 UTC

Обсуждения рынка

Basic Materials Roundup: Market Talk

7 окт. 2025 г., 20:44 UTC

Популярные акции

Stocks to Watch Tuesday Recap: Oracle, Dell, Trilogy Metals -- WSJ

7 окт. 2025 г., 19:42 UTC

Обсуждения рынка

Treasury Yields Fall as Data Blackout Continues -- Market Talk

7 окт. 2025 г., 19:23 UTC

Приобретения, слияния, поглощения

Private-Equity Stocks Have Gotten Crushed. J.P. Morgan Says This One Is a Buy. -- Barrons.com

7 окт. 2025 г., 19:07 UTC

Обсуждения рынка

Oil Futures Settle Mixed With Higher OPEC+ Supply in View -- Market Talk

7 окт. 2025 г., 19:02 UTC

Обсуждения рынка

U.S. Natural Gas Posts Back-to-Back Gains -- Market Talk

7 окт. 2025 г., 16:20 UTC

Обсуждения рынка

Tech, Media & Telecom Roundup: Market Talk

7 окт. 2025 г., 16:20 UTC

Обсуждения рынка

Basic Materials Roundup: Market Talk

7 окт. 2025 г., 16:20 UTC

Обсуждения рынка

Home Depot Extended Pro Desk Hours Could Drive Sales Growth -- Market Talk

7 окт. 2025 г., 16:15 UTC

Обсуждения рынка

AMD's OpenAI Deal Resets Competitive Landscape for Chips -- Market Talk

7 окт. 2025 г., 16:15 UTC

Обсуждения рынка

Global Commodities Roundup: Market Talk

7 окт. 2025 г., 15:37 UTC

Обсуждения рынка

Global Forex and Fixed Income Roundup: Market Talk

7 окт. 2025 г., 15:37 UTC

Обсуждения рынка

Markets for Canadian Aluminum Open Up Beyond U.S. -- Market Talk

7 окт. 2025 г., 15:33 UTC

Обсуждения рынка

Gold Rise Tied to Lower Confidence in Dollar Assets -- Market Talk

7 окт. 2025 г., 15:25 UTC

Обсуждения рынка

Canadian Mining Stocks Rally on U.S. Defense Dept. Deal -- Market Talk

7 окт. 2025 г., 15:15 UTC

Обсуждения рынка

Investors Look to Gold, Bitcoin as Traditional Correlations Break Down -- Market Talk

7 окт. 2025 г., 15:04 UTC

Обсуждения рынка

Market Talk Roundup: Latest on U.S. Politics

7 окт. 2025 г., 15:04 UTC

Обсуждения рынка

Canadian Aluminum Exports Squeezed by Tariffs -- Market Talk

7 окт. 2025 г., 14:56 UTC

Обсуждения рынка

Global Forex and Fixed Income Roundup: Market Talk

7 окт. 2025 г., 14:56 UTC

Обсуждения рынка

U.S. Government Shutdown May Impact Release of Canadian Trade Data -- Market Talk

7 окт. 2025 г., 14:52 UTC

Отчет

These Stocks Are Moving the Most Today: Tesla, AMD, Ford, Dell, IBM, AppLovin, Trilogy Metals, Aehr, and More -- Barrons.com

Сравнение c конкурентами

Изменение цены

Maravai LifeSciences Holdings Inc (Class A) Прогноз

Целевая цена

By TipRanks

49.68% рост

Прогноз на 12 месяцев

Средняя 4.67 USD  49.68%

Максимум 5 USD

Минимум 4 USD

Основано на мнении 6 аналитиков Wall Street, спрогнозировавших целевые цены для Maravai LifeSciences Holdings Inc (Class A) на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Покупка

6 ratings

4

Покупка

2

Удержание

0

Продажа

Техническая оценка

By Trading Central

2.02 / 2.115Поддержка и Сопротивление

Краткосрочная

Bullish Evidence

Среднесрочная

Strong Bullish Evidence

Долгосрочная

No Evidence

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Maravai LifeSciences Holdings Inc (Class A)

Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases worldwide. The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, antibody-based products to detect impurities during the production of biopharmaceutical products, and products to detect the expression of proteins in tissues of various species. It operates in two segments, Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment manufactures and sells products for use in the fields of gene therapy, vaccines, nucleoside chemistry, oligonucleotide therapy, and molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling, and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). This segment also offers messenger RNA, oligonucleotides, and oligonucleotide building blocks, as well as custom enzyme development and manufacturing and CleanCap capping technology. The Biologics Safety Testing segment sells analytical products for use in biologic manufacturing process development, including custom product-specific development antibody, and assay development services. This segment also provides HCP ELISA kits, other bioprocess impurity and contaminant ELISA kits, ancillary reagents, viral clearance prediction kits, and custom services. The company serves biopharmaceutical companies, and other biopharmaceutical and life sciences research companies; and academic research institutions and in vitro diagnostics companies. The company was incorporated in 2020 and is headquartered in San Diego, California.
help-icon Live chat